AstraZeneca Pharma India Limited
₹8,725+5.13%Apr 13, 3:45 PM IST
ASTRAZEN•Health Technology•Pharmaceuticals: Major
Current Price
₹8,725+5.13%
Apr 13, 3:45 PM ISTMarket Cap₹20,728.75 Cr
Market Cap₹20,728.75 Cr
Business Overview
AstraZeneca Pharma India Limited operates through 3 main business divisions including Science & Innovation, Growth & Therapy Area Leadership, People and Sustainability.
Business Hierarchy Structure for AstraZeneca Pharma India Limited
- AstraZeneca Pharma India Limited
- Science & Innovation
- Growth & Therapy Area Leadership
- BioPharmaceuticals
- Cardiovascular, Renal & Metabolism (CVRM)
- Forxiga (Dapagliflozin)
- Brilinta (Ticagrelor)
- Andexanet Alfa
- Seloken XL
- Respiratory & Immunology (R&I)
- Symbicort
- Fasenra (Benralizumab)
- Cardiovascular, Renal & Metabolism (CVRM)
- Oncology
- Lung Cancer
- Tagrisso (Osimertinib)
- Imfinzi (Durvalumab)
- Enhertu (Trastuzumab Deruxtecan)
- Breast Cancer
- Enhertu (Trastuzumab Deruxtecan)
- Gastrointestinal Cancer
- Imfinzi (Durvalumab)
- Enhertu (Trastuzumab Deruxtecan)
- Genitourinary/Gynecological Cancers
- Lynparza (Olaparib)
- Zoladex
- Lung Cancer
- Rare Diseases
- Neurofibromatosis type 1 (NF1)
- Koselugo (Selumetinib)
- Neurofibromatosis type 1 (NF1)
- BioPharmaceuticals
- People and Sustainability
- A.Catalyst Network
- Project SEARCH
- Heart Mitra Digital Cardiac Rehabilitation Programme
- Ganga Godavari Screening Programme
- Young Health Programme (YHP)
- AZ Forest
- Improved Cookstove Project